Get started
Author

Stephanie Begley

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice
2024 · Aleksander Chojecki, Danielle Boselli, et al. · Annals of Hematology · 5
PDF
High Ki67 Index Is Associated with Shorter Progression Free Survival in Follicular Lymphoma Patients Treated with Frontline Immunochemotherapy
2023 · Jianmin Han, Chad M McCall, et al. · Blood · 2
PDF
Impact of Race, Ethnicity, and Social Determinants of Heath on Outcomes for Acute Myeloid Leukemia Patients in a System with Specialized Nurse Navigation
2022 · Brittany Knick Ragon, Danielle Boselli, et al. · Blood · 2
Distress and Care Utilization in Patients with Myeloproliferative Neoplasms
2025 · Rushil Virendra Patel, Danielle Boselli, et al. · Acta Haematologica · 1
Outcomes with Real-World Use of Azacitidine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Are Comparable to Long-Term Viale-a Results
2024 · Zalak Shah, Danielle Boselli, et al. · Blood · 1
Neighborhood Disadvantage Is Associated with Inferior Overall Survival for Acute Myeloid Leukemia Patients Treated with Standard Intensive Induction
2023 · Brittany Knick Ragon, Danielle Boselli, et al. · Blood · 1
PDF
Measuring the Incidence of Distress and Supportive Oncology Utilization Among Patients with Myeloproliferative Neoplasms: A Single Center Experience
2022 · Rushil V. Patel, Danielle Boselli, et al. · Blood · 1
Treatment patterns and outcomes of primary central nervous system lymphoma treated with high-dose methotrexate with or without autologous stem cell transplantation or whole brain radiation in the rea-world setting
2025 · Yifan Pang, Caroline Horne, et al. · Blood
High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy
2024 · Jianmin Han, Chad M. McCall, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib.
2023 · Aleksander Lech Chojecki, Danielle Boselli, et al. · Journal of Clinical Oncology
Works count: 10
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type